Manesh Raman Patel

Chief, Division of Clinical Pharmacology · Duke Department of Medicine

Credentials: ·

History

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
New England Journal of Medicine · 2011 · First of 17 authors · Corresponding · 7,354 citations
Low diagnostic yield of elective coronary angiography
New England Journal of Medicine · 2010 · First of 8 authors · Corresponding · 1,328 citations
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
European Journal of Vascular and Endovascular Surgery · 2019 · 1,220 citations

1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
National Heart, Lung, and Blood Institute · UH3
Contact PI · $5.6M · Duke University
2023–2030
1/2 Low Dose Colchicine in pAtients with Peripheral Artery DiseasE to Assess Residual Vascular Risk (LEADER-PAD)
National Heart, Lung, and Blood Institute · UH3
Contact PI · $3.7M · Duke University
2024–2029
1/2 Low Dose Colchicine in pAtients with Peripheral Artery DiseasE to Assess Residual Vascular Risk (LEADER-PAD)
National Heart, Lung, and Blood Institute · UG3
Contact PI · $1.9M · Duke University
2024–2025
Solving Sepsis: Early Identification and Prompt Management Using Machine Learning
National Institute of General Medical Sciences · R42
Contact PI · $2.1M · Cohere-Med, Inc.
2022–2025

Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction
Principal investigator · Recruiting
Duke University
2025–2029
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Principal investigator · Recruiting
Duke University
2024–2030
Hearts of Athletes
Principal investigator · Terminated
Duke University
2022–2025
BEST vCLI Registry
Principal investigator · Completed
Duke University
2019–2023